Strategic Partnerships Leverage Enlighten Mobility's recent collaboration with Gravitrex Mobility to explore co-development, distribution, or joint pilots in neuromotor rehabilitation devices, potentially expanding market reach and credibility.

Clinical Roots Target hospitals, NICUs, and pediatric care centers connected to previous initiatives like Nationwide Children's Hospital and EDNA projects to present GMat and related neuromotor screening solutions as validated or near-market options.

Acquisition Leverage Monitor asset divestiture activity such as the EDNA portfolio sale to AngelEye Health as an opening to discuss complementary rehabilitation and early intervention tools that fit into post-acute mobility care pathways.

Early Intervention Focus Position Enlighten Mobility’s early detection and intervention capabilities to value-based care buyers seeking prevention and optimization of mobility recovery, aligning with payer and provider incentives for reduced long-term impairment costs.

Funding and Validation Highlight prior funding and academia-backed initiatives (GMat development with Maitre and Ohio funding) to engage grant-ready or venture-backed clients and partners seeking evidence-based, clinically validated solutions.